Starlight Cardiovascular announced that the first baby in the world was treated with its Lifeline(TM) Ductus Arteriosus Stent System at Cincinnati Children's Hospital in January. The device is ...

Medical device and healthcare company Abbott arranged to have their canine and kid patients treated for patent ductus ...

Starlight Cardiovascular announced today that the first baby in the world received treatment with its Lifeline pediatric ...

Merit Medical Systems initiates a study to evaluate the Bloom Micro Occluder System for treating patent ductus arteriosus in premature infants. Merit Medical Systems, Inc. has announced the enrollment ...

From the Laboratory of Surgical Research, Harvard Medical School, and the Department of Surgery, Children's Hospital, Boston. Select the format you want to export the citation of this publication.

A randomized controlled trial evaluates if selective early treatment of patent ductus arteriosus reduces death or bronchopulmonary dysplasia at 36 weeks in extreme preterm babies. Findings from the ...

Evidence-based recommendations on endovascular closure of patent ductus arteriosus. This involves placing a blocking device into the heart, which stays in place permanently and the body’s tissue grows ...

The cyclooxygenase inhibitor ibuprofen may be used to treat patent ductus arteriosus (PDA) in preterm infants. Whether selective early treatment of large PDAs with ibuprofen would improve short-term ...

Current evidence on the safety and efficacy of endovascular closure of patent ductus arteriosus (PDA) appears adequate to support the use of this procedure provided that the normal arrangements are in ...